Research Paper Volume 15, Issue 13 pp 6526—6544
N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer
Figure 9. Correlation of N6AMT1 expression with immunotherapy markers and immunotherapy response. (A) Correlations of N6AMT1 expression with PDL1, MSI and TMB. (B) Correlations of N6AMT1 expression with MMR-related genes. (C) Differences in N6AMT1 expression between responder and non-responder groups in the three immunotherapy cohorts. (D) Differential analysis of mRNA expression of N6AMT1 in HCC in GEPIA2.0 database. (E) Expression levels of N6AMT1 in normal liver cell lines and HCC cell lines. *: p < 0.05, **: p < 0.01, ***: p < 0.001.